TY - JOUR
T1 - Atrial natriuretic factor
T2 - Assessment of its structure in atria and regulation of its biosynthesis with volume depletion
AU - Zisfein, Jerome B.
AU - Matsueda, Gary R.
AU - Fallon, John T.
AU - Bloch, Kenneth D.
AU - Seidman, Christine E.
AU - Seidman, Jonathan G.
AU - Homcy, Charles J.
AU - Graham, Robert M.
N1 - Funding Information:
This work was supported, in part, by NIH training grant HL07208 (JBZ), NIH grant HL26215 (JTF), a fellowship from the Leukemia Society of America (KDB), NIH grants HL19259 and NS19583-04 and a grant from the R.J. Reynolds Co. (CJH and RMG) and a fellowship from the Mallinckrodt Foundation and NIH grant AI 18436 (JGS). CJH and RMG are Established Investigators, American Heart Foundation (AHA80-148, 82-240).
PY - 1986/9
Y1 - 1986/9
N2 - Atrial natriuretic factor(ANF) is a polypeptide that has been isolated from mammalian atrial tissue with potent natriuretic, diuretic and spasmolytic properties. Details of its biosynthesis, cleavage, storage and release are not yet fully defined. Using sequence-specific anti-peptide antisera in immunocytochemical and radioimmunoassay studies, we demonstrated the presence in atrial granules of sequences corresponding to both the large molecular weight ("prohormone") form of ANF and the carboxyterminal peptide believed to be responsible for its biological activity. However, a peptide sequence spanning the proposed site of cleavage of the "signal peptide" from preproANF was undetected. In volume-depleted rats, a 28% decrease in the relative concentrations of atrial ANF mRNA was observed ascompared to that of controls (P<0.01). There was, however, no significant difference observed between the two groups of animals with respect to atrial levels of ANF, as measured by radioimmunoassay. We conclude from these studies that proANF, but not preproANF, is stored in atrial granules. The concentration of stored ANF remains constant in volume-depeleted rats despite a 28% reduction in ambient levels of ANF mRNA. The physiologic significance of these findings is discussed.
AB - Atrial natriuretic factor(ANF) is a polypeptide that has been isolated from mammalian atrial tissue with potent natriuretic, diuretic and spasmolytic properties. Details of its biosynthesis, cleavage, storage and release are not yet fully defined. Using sequence-specific anti-peptide antisera in immunocytochemical and radioimmunoassay studies, we demonstrated the presence in atrial granules of sequences corresponding to both the large molecular weight ("prohormone") form of ANF and the carboxyterminal peptide believed to be responsible for its biological activity. However, a peptide sequence spanning the proposed site of cleavage of the "signal peptide" from preproANF was undetected. In volume-depleted rats, a 28% decrease in the relative concentrations of atrial ANF mRNA was observed ascompared to that of controls (P<0.01). There was, however, no significant difference observed between the two groups of animals with respect to atrial levels of ANF, as measured by radioimmunoassay. We conclude from these studies that proANF, but not preproANF, is stored in atrial granules. The concentration of stored ANF remains constant in volume-depeleted rats despite a 28% reduction in ambient levels of ANF mRNA. The physiologic significance of these findings is discussed.
KW - ANF mRNA
KW - Atrial granules
KW - Immunocytochemistry
UR - https://www.scopus.com/pages/publications/0022878388
U2 - 10.1016/S0022-2828(86)80006-2
DO - 10.1016/S0022-2828(86)80006-2
M3 - Article
C2 - 2946873
AN - SCOPUS:0022878388
SN - 0022-2828
VL - 18
SP - 917
EP - 929
JO - Journal of Molecular and Cellular Cardiology
JF - Journal of Molecular and Cellular Cardiology
IS - 9
ER -